Nuclear Receptor and Stress Response Pathways Associated with Antineoplastic Agent-Induced Diarrhea

Int J Mol Sci. 2022 Oct 17;23(20):12407. doi: 10.3390/ijms232012407.

Abstract

In severe cases, antineoplastic agent-induced diarrhea may be life-threatening; therefore, it is necessary to determine the mechanism of toxicity and identify the optimal management. The mechanism of antineoplastic agent-induced diarrhea is still unclear but is often considered to be multifactorial. The aim of this study was to determine the molecular initiating event (MIE), which is the initial interaction between molecules and biomolecules or biosystems, and to evaluate the MIE specific to antineoplastic agents that induce diarrhea. We detected diarrhea-inducing drug signals based on adjusted odds ratios using the Food and Drug Administration Adverse Event Reporting System. We then used the quantitative structure-activity relationship platform of Toxicity Predictor to identify potential MIEs that are specific to diarrhea-inducing antineoplastic agents. We found that progesterone receptor antagonists were potential MIEs associated with diarrhea. The findings of this study may help improve the prediction and management of antineoplastic agent-induced diarrhea.

Keywords: cancer; drug-induced diarrhea; molecular initiating event.

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Diarrhea / chemically induced
  • Diarrhea / drug therapy
  • Humans
  • Pharmaceutical Preparations
  • Quantitative Structure-Activity Relationship
  • Receptors, Progesterone*
  • United States

Substances

  • Receptors, Progesterone
  • Antineoplastic Agents
  • Pharmaceutical Preparations